Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 6
2011 2
2012 1
2013 2
2014 1
2016 1
2018 5
2019 1
2020 4
2021 3
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
BCG in Bladder Cancer Immunotherapy.
Jiang S, Redelman-Sidi G. Jiang S, et al. Among authors: redelman sidi g. Cancers (Basel). 2022 Jun 23;14(13):3073. doi: 10.3390/cancers14133073. Cancers (Basel). 2022. PMID: 35804844 Free PMC article. Review.
Could BCG be used to protect against COVID-19?
Redelman-Sidi G. Redelman-Sidi G. Nat Rev Urol. 2020 Jun;17(6):316-317. doi: 10.1038/s41585-020-0325-9. Nat Rev Urol. 2020. PMID: 32341531 Free PMC article. Review.
Complications of Intravesical BCG Immunotherapy for Bladder Cancer.
Green DB, Kawashima A, Menias CO, Tanaka T, Redelman-Sidi G, Bhalla S, Shah R, King BF. Green DB, et al. Among authors: redelman sidi g. Radiographics. 2019 Jan-Feb;39(1):80-94. doi: 10.1148/rg.2019180014. Epub 2018 Dec 7. Radiographics. 2019. PMID: 30526332 Review.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).
Redelman-Sidi G, Michielin O, Cervera C, Ribi C, Aguado JM, Fernández-Ruiz M, Manuel O. Redelman-Sidi G, et al. Clin Microbiol Infect. 2018 Jun;24 Suppl 2(Suppl 2):S95-S107. doi: 10.1016/j.cmi.2018.01.030. Epub 2018 Feb 7. Clin Microbiol Infect. 2018. PMID: 29427804 Free PMC article. Review.
The Canonical Wnt Pathway Drives Macropinocytosis in Cancer.
Redelman-Sidi G, Binyamin A, Gaeta I, Palm W, Thompson CB, Romesser PB, Lowe SW, Bagul M, Doench JG, Root DE, Glickman MS. Redelman-Sidi G, et al. Cancer Res. 2018 Aug 15;78(16):4658-4670. doi: 10.1158/0008-5472.CAN-17-3199. Epub 2018 Jun 5. Cancer Res. 2018. PMID: 29871936 Free PMC article.
Determinants of COVID-19 disease severity in patients with cancer.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa CJ, Glickman MS, Joanow A, Kaltsas A, Lee YJ, Lucca A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah MK, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Robilotti EV, et al. Among authors: redelman sidi g. Nat Med. 2020 Aug;26(8):1218-1223. doi: 10.1038/s41591-020-0979-0. Epub 2020 Jun 24. Nat Med. 2020. PMID: 32581323 Free PMC article.
27 results